116 related articles for article (PubMed ID: 33675911)
1. Role of surface molecular environment and amorphous content in moisture sorption behavior of milled Terbutaline Sulphate.
Bagwan NUS; Sheokand S; Kaur A; Dubey G; Puri V; Bharatam PV; Bansal AK
Eur J Pharm Sci; 2021 Jun; 161():105782. PubMed ID: 33675911
[TBL] [Abstract][Full Text] [Related]
2. Applicability of the one-step DVS method for the determination of amorphous amounts for further different hydrophilic and hydrophobic drugs.
Müller T; Scherließ R; Schiewe J; Smal R; Weiler C; Steckel H
Eur J Pharm Biopharm; 2015 Aug; 94():333-41. PubMed ID: 26079523
[TBL] [Abstract][Full Text] [Related]
3. Investigating the moisture sorption behavior of amorphous sucrose using a dynamic humidity generating instrument.
Yu X; Kappes SM; Bello-Perez LA; Schmidt SJ
J Food Sci; 2008 Jan; 73(1):E25-35. PubMed ID: 18211350
[TBL] [Abstract][Full Text] [Related]
4. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
Lau M; Young PM; Traini D
Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
[TBL] [Abstract][Full Text] [Related]
5. Molecular Basis of Water Sorption Behavior of Rivaroxaban-Malonic Acid Cocrystal.
Kale DP; Ugale B; Nagaraja CM; Dubey G; Bharatam PV; Bansal AK
Mol Pharm; 2019 Jul; 16(7):2980-2991. PubMed ID: 31244222
[TBL] [Abstract][Full Text] [Related]
6. Quantification of low levels of amorphous content in crystalline celecoxib using dynamic vapor sorption (DVS).
Sheokand S; Modi SR; Bansal AK
Eur J Pharm Biopharm; 2016 May; 102():77-86. PubMed ID: 26948976
[TBL] [Abstract][Full Text] [Related]
7. Measurement of low amounts of amorphous content in hydrophobic active pharmaceutical ingredients with dynamic organic vapor sorption.
Müller T; Schiewe J; Smal R; Weiler C; Wolkenhauer M; Steckel H
Eur J Pharm Biopharm; 2015 May; 92():102-11. PubMed ID: 25779351
[TBL] [Abstract][Full Text] [Related]
8. Correlation between molecular dynamics and physical stability of two milled anhydrous sugars: Lactose and sucrose.
Smith G; Hussain A; Bukhari NI; Ermolina I
Int J Pharm; 2018 Nov; 551(1-2):184-194. PubMed ID: 30223078
[TBL] [Abstract][Full Text] [Related]
9. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.
Balani PN; Wong SY; Ng WK; Widjaja E; Tan RB; Chan SY
Int J Pharm; 2010 May; 391(1-2):125-36. PubMed ID: 20211717
[TBL] [Abstract][Full Text] [Related]
10. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
[TBL] [Abstract][Full Text] [Related]
11. Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials.
Sheokand S; Modi SR; Bansal AK
J Pharm Sci; 2014 Nov; 103(11):3364-3376. PubMed ID: 25213429
[TBL] [Abstract][Full Text] [Related]
12. Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acids.
Curtin V; Amharar Y; Gallagher KH; Corcoran S; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2013 Nov; 456(2):508-16. PubMed ID: 23994365
[TBL] [Abstract][Full Text] [Related]
13. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
Balani PN; Ng WK; Tan RB; Chan SY
J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
[TBL] [Abstract][Full Text] [Related]
14. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
[TBL] [Abstract][Full Text] [Related]
15. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
[TBL] [Abstract][Full Text] [Related]
16. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
17. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
Chen H; Pui Y; Liu C; Chen Z; Su CC; Hageman M; Hussain M; Haskell R; Stefanski K; Foster K; Gudmundsson O; Qian F
J Pharm Sci; 2018 Jan; 107(1):317-326. PubMed ID: 29107047
[TBL] [Abstract][Full Text] [Related]
18. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
[TBL] [Abstract][Full Text] [Related]
20. The use of organic vapor sorption to determine low levels of amorphous content in processed pharmaceutical powders.
Young PM; Chiou H; Tee T; Traini D; Chan HK; Thielmann F; Burnett D
Drug Dev Ind Pharm; 2007 Jan; 33(1):91-7. PubMed ID: 17192255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
